Drug Profile
RO 0256981
Latest Information Update: 13 Jul 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Neuroprotectants; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 18 Sep 2002 Preclinical trials in Neurological disorders (Prevention) in Switzerland (unspecified route)